Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report)’s share price dropped 0.5% on Monday . The stock traded as low as $8.67 and last traded at $8.74. Approximately 159,587 shares were traded during mid-day trading, an increase of 223% from the average daily volume of 49,363 shares. The stock had previously closed at $8.78.
Wall Street Analyst Weigh In
Separately, Citigroup raised Fresenius SE & Co. KGaA to a “strong-buy” rating in a research note on Friday, October 25th.
Get Our Latest Stock Analysis on Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Trading Down 0.5 %
About Fresenius SE & Co. KGaA
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Featured Stories
- Five stocks we like better than Fresenius SE & Co. KGaA
- 3 Fintech Stocks With Good 2021 Prospects
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- How to Calculate Stock Profit
- Applied Materials Market Capitulates: Now is the Time to Buy
- Investing in Travel Stocks Benefits
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.